Matthew A Moffa
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 8
-
- Clostridium difficile and Clostridium perfringens research 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Thomas Walsh (25 shared papers)Derek N. Bremmer (21 shared papers)Courtney Watson (6 shared papers)Briana DiSilvio (6 shared papers)Nitin Bhanot (3 shared papers)Joseph Timpone (1 shared paper)Sameer S. Kadri (1 shared paper)Samuel F. Hohmann (1 shared paper)
- Journals
- Open Forum Infectious Diseases (8 papers)Clinical Infectious Diseases (3 papers)Infection (2 papers)Journal of General Internal Medicine (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- United StatesPoland
In The Last Decade
Matthew A Moffa
25 papers receiving 258 citations
Peers
Comparison fields: 5 of 59
- Applied Microbiology and Biotechnology 81
- Clinical Biochemistry 45
- Molecular Medicine 22
- Critical Care and Intensive Care Medicine 19
- Infectious Diseases 38
Countries citing papers authored by Matthew A Moffa
This map shows the geographic impact of Matthew A Moffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A Moffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A Moffa more than expected).
Fields of papers citing papers by Matthew A Moffa
This network shows the impact of papers produced by Matthew A Moffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A Moffa. The network helps show where Matthew A Moffa may publish in the future.
Co-authors
The 24 scholars most cited alongside Matthew A Moffa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 34 | |
| 2 | 2019 | 30 | |
| 3 | 2018 | 23 | |
| 4 | 2021 | 22 | |
| 5 | 2020 | 22 | |
| 6 | 2021 | 20 | |
| 7 | 2017 | 18 | |
| 8 | 2014 | 18 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 2019 | 8 | |
| 13 | 2018 | 7 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Matthew A Moffa
Matthew A Moffa is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Epidemiology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 27 papers that have together received 264 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Pneumonia and Respiratory Infections (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Patient Satisfaction in Healthcare (2 papers), Bacterial Infections and Vaccines (2 papers), Herpesvirus Infections and Treatments (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (81 citations), Clinical Biochemistry (45 citations), Molecular Medicine (22 citations), Critical Care and Intensive Care Medicine (19 citations) and Infectious Diseases (38 citations). Matthew A Moffa has collaborated with scholars based in United States and Poland. Frequent co-authors include Thomas Walsh, Derek N. Bremmer, Courtney Watson, Briana DiSilvio, Nitin Bhanot, Joseph Timpone, Sameer S. Kadri, Samuel F. Hohmann, Kenneth B. Christopher and E. John Orav. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Infection, Journal of General Internal Medicine and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.